Drug recall · September 26, 2018
MethylPREDNISolone Tablets recall
Why: Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03
- Lots / codes
Lot # 17P0078, exp. date 12/2018
- Quantity
- 89,722 blister pack
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Product was distributed throughout the United States.
- Initiated
- August 27, 2018 · Voluntary: Firm initiated
- Classified
- September 21, 2018
- Reported
- September 26, 2018
- Ended
- October 8, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylprednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.